Ambu A/S header image

Ambu A/S

AMBU B

Equity

ISIN DK0060946788 / Valor 39639588

Nasdaq Copenhagen Equities (2026-03-26)
DKK 69.25+1.69%

Ambu A/S
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Ambu A/S is a Danish multinational medical technology company specializing in the development, manufacturing, and distribution of single-use endoscopy solutions, as well as products for anesthesia and patient monitoring. The company is recognized as a market leader in single-use endoscopy, offering a comprehensive portfolio that covers pulmonology, urology, ear-nose-throat (ENT), and gastroenterology (GI). Ambu's endoscopes are designed to operate on a unified platform, providing healthcare professionals with an interconnected system that enhances workflow efficiency and patient care. In addition to its endoscopy solutions, Ambu maintains a strong presence in the fields of anesthesia and patient monitoring, with a legacy that includes the invention of the first self-inflating resuscitator, known as the "Ambu bag," in 1956. The company operates globally, with production facilities in the USA, China, Malaysia, and Mexico, and serves over 100 million patients worldwide. Ambu's commitment to innovation and quality continues to drive its mission to support healthcare professionals in saving lives and improving patient outcomes.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-43.4%1Y
-27.2%3Y
-74.5%5Y

Performance

39.4%1Y
39.8%3Y
48.8%5Y

Volatility

Market cap

2472 M

Market cap (USD)

Daily traded volume (Shares)

875,588

Daily traded volume (Shares)

1 day high/low

107.55 / 106.1

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Janux Therapeutics Inc
Janux Therapeutics Inc Janux Therapeutics Inc Valor: 111742522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.23%USD 13.63
GSK PLC
GSK PLC GSK PLC Valor: 120042705
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.39%USD 53.94
The Platform Group AG
The Platform Group AG The Platform Group AG Valor: 57796644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-7.31%EUR 2.85
Healthcare Services Group Inc
Healthcare Services Group Inc Healthcare Services Group Inc Valor: 938239
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.95%USD 19.11
Amgen Inc
Amgen Inc Amgen Inc Valor: 907582
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.22%USD 353.16
STERIS PLC
STERIS PLC STERIS PLC Valor: 47027903
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.02%USD 223.43
Molina Healthcare Inc
Molina Healthcare Inc Molina Healthcare Inc Valor: 1538184
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.74%USD 138.80
Quest Diagnostics Inc
Quest Diagnostics Inc Quest Diagnostics Inc Valor: 566162
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.86%USD 198.15
Astrana Health Inc
Astrana Health Inc Astrana Health Inc Valor: 28041888
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.86%USD 24.27
Alnylam Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc Alnylam Pharmaceuticals Inc Valor: 1806798
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.16%USD 328.16